N
CPRX icon

Natixis’s Catalyst Pharmaceutical CPRX Stock Holding History

Natixis’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-87,572
Closed -$1.73M – 1160
2025
Q3 		$1.73M Buy
+87,572
New +$1.8M 0.01% 592
2023
Q4 		– Sell
-108,300
Closed -$1.27M – 1067
2023
Q3 		$1.27M Buy
+108,300
New +$1.45M 0.01% 465
2022
Q2 		– Sell
-225,377
Closed -$1.87M – 1192
2022
Q1 		$1.87M Sell
225,377
-10,643
-5% -$75.2K 0.01% 766
2021
Q4 		$1.6M Buy
+236,020
New +$1.55M 0.01% 831

Other funds holding CPRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return